BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28595944)

  • 21. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.
    Chen LM; Bao CH; Wu Y; Liang SH; Wang D; Wu LY; Huang Y; Liu HR; Wu HG
    J Neuroinflammation; 2021 Jun; 18(1):135. PubMed ID: 34127024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice.
    Zhou M; Fan Y; Xu L; Yu Z; Wang S; Xu H; Zhang J; Zhang L; Liu W; Wu L; Yu J; Yao H; Wang J; Gao R
    Microbiome; 2023 Jun; 11(1):145. PubMed ID: 37386523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
    Bhattacharyya S; Ahmed AT; Arnold M; Liu D; Luo C; Zhu H; Mahmoudiandehkordi S; Neavin D; Louie G; Dunlop BW; Frye MA; Wang L; Weinshilboum RM; Krishnan RR; Rush AJ; Kaddurah-Daouk R
    Transl Psychiatry; 2019 Jul; 9(1):173. PubMed ID: 31273200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression.
    Lu Q; Mouri A; Yang Y; Kunisawa K; Teshigawara T; Hirakawa M; Mori Y; Yamamoto Y; Libo Z; Nabeshima T; Saito K
    Behav Brain Res; 2019 Oct; 372():112053. PubMed ID: 31288060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
    Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
    Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas.
    Vigo DV; Kestel D; Pendakur K; Thornicroft G; Atun R
    Lancet Public Health; 2019 Feb; 4(2):e89-e96. PubMed ID: 30446416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination.
    Zhang Y; Du L; Bai Y; Han B; He C; Gong L; Huang R; Shen L; Chao J; Liu P; Zhang H; Zhang H; Gu L; Li J; Hu G; Xie C; Zhang Z; Yao H
    Mol Psychiatry; 2020 Jun; 25(6):1175-1190. PubMed ID: 30413800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
    El-Haggar SM; Eissa MA; Mostafa TM; El-Attar KS; Abdallah MS
    Psychother Psychosom; 2018; 87(6):331-339. PubMed ID: 30205379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.
    Laurans L; Venteclef N; Haddad Y; Chajadine M; Alzaid F; Metghalchi S; Sovran B; Denis RGP; Dairou J; Cardellini M; Moreno-Navarrete JM; Straub M; Jegou S; McQuitty C; Viel T; Esposito B; Tavitian B; Callebert J; Luquet SH; Federici M; Fernandez-Real JM; Burcelin R; Launay JM; Tedgui A; Mallat Z; Sokol H; Taleb S
    Nat Med; 2018 Aug; 24(8):1113-1120. PubMed ID: 29942089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Bidirectional Relationship of Depression and Inflammation: Double Trouble.
    Beurel E; Toups M; Nemeroff CB
    Neuron; 2020 Jul; 107(2):234-256. PubMed ID: 32553197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer's Disease via Gut Microbiome.
    Torraville SE; Flynn CM; Kendall TL; Yuan Q
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cinnamon oil solid self-microemulsion mediates chronic mild stress-induced depression in mice by modulating monoamine neurotransmitters, corticosterone, inflammation cytokines, and intestinal flora.
    Ma T; Tang B; Wang Y; Shen M; Ping Y; Wang L; Su J
    Heliyon; 2023 Jun; 9(6):e17125. PubMed ID: 37416658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression.
    Huang X; Wang B; Yang J; Lian YJ; Yu HZ; Wang YX
    Brain Behav Immun Health; 2023 Jul; 30():100641. PubMed ID: 37288063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
    Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
    Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression.
    Wang G; An T; Lei C; Zhu X; Yang L; Zhang L; Zhang R
    J Ginseng Res; 2022 May; 46(3):376-386. PubMed ID: 35600767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of Indoleamine 2, 3-dioxygenase 1 ameliorates hippocampal neurogenesis and BOLD-fMRI signals in chronic stress precipitated depression.
    Gao L; Gao T; Zeng T; Huang P; Wong NK; Dong Z; Li Y; Deng G; Wu Z; Lv Z
    Aging (Albany NY); 2021 Feb; 13(4):5875-5891. PubMed ID: 33591947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota, kynurenine pathway and mental disorders - Review.
    Więdłocha M; Marcinowicz P; Janoska-Jaździk M; Szulc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110145. PubMed ID: 33203568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment.
    Günther J; Däbritz J; Wirthgen E
    Front Immunol; 2019; 10():1801. PubMed ID: 31417567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.
    Aldrich SL; Poweleit EA; Prows CA; Martin LJ; Strawn JR; Ramsey LB
    Front Pharmacol; 2019; 10():99. PubMed ID: 30837874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.